This care card's answer
Ask for the product name as well.
As of September 26, 2026, U.S. rules depend on which medicine is offered and what it is meant to do. The word peptide alone does not answer that.
Knowing the ingredient name does not tell you whether the medicine you would receive has been approved.
Sort the answer before comparing options.
Ask whether the proposed product is an approved medicine, a made-to-order preparation or something labelled for research. Then ask what the choice means for your care.
A name can still leave a question open.
Write down the full product name and its form: a tablet, an injection or something else. Bring that note to the visit. It is easier to discuss a specific product than a broad term like peptide therapy.
Take this to the conversation
Which finished product are we talking about, and what evidence supports this use?
Ask for the answer in plain words. Keep it with your visit notes.
Notes behind this answer
- FDA: finished products and compounding
Explains how medicines made to order differ from approved products.
- FDA: semaglutide product label
A product label sets out the particular uses reviewed by the agency.